5 best CRISPR stocks to buy 5 best CRISPR stocks to buy Not every investor will want to buy CRISPR gene-editing stocks. These stocks tend to be highly risky and volatile. However, for aggressive ...
In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report), ...
On December 13, Truist Securities upgraded Sangamo’s stock from Hold to Buy, setting a price target ... the introduction of the QIAprep& CRISPR Kit and CRISPR Q-Primer Solutions, which ...
Qiagen NV (NYSE:QGEN) recently enhanced its product offerings with the introduction of the QIAprep& CRISPR Kit and CRISPR Q-Primer ... QGEN) with a Buy rating and a price target of $54.
CRISPR Therapeutics AG (CRSP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
Qiagen NV (NYSE:QGEN) recently enhanced its product offerings with the introduction of the QIAprep& CRISPR Kit and CRISPR Q-Primer ... QGEN) with a Buy rating and a price target of $54.